Octagon Capital Advisors LP ARRIVENT BIOPHARMA INC Transaction History
Octagon Capital Advisors LP
- $414 Million
- Q3 2024
Number of Shares
1,976,387
Previous 1,803,304
9.6%
Holding current value
$0
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%